Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for First Comprehensive Real-World Analysis of CRS/ICANS Management, Escalation Patterns, and Outcomes Across CD3ΧCD20 Bispecific Antibodies in Lymphoma

ABCL - 1342

First Comprehensive Real-World Analysis of CRS/ICANS Management, Escalation Patterns, and Outcomes Across CD3ΧCD20 Bispecific Antibodies in Lymphoma

Youssef Samaha

Poster Presenter: Youssef Samaha

Thumbnail for Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

ABCL - 1368

Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

Shivam Patel

Poster Presenter: Shivam Patel

Thumbnail for Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

ABCL - 1385

Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

Srijani Thannir

Poster Presenter: Srijani Thannir

Thumbnail for Secondary Primary Malignancies Associated With CD20ΧCD3 Bispecific T-Cell Engaging Antibodies in Patients With B-Cell Non-Hodgkin's Lymphoma

ABCL - 1388

Secondary Primary Malignancies Associated With CD20ΧCD3 Bispecific T-Cell Engaging Antibodies in Patients With B-Cell Non-Hodgkin's Lymphoma

Carmel Awadallah

Poster Presenter: Carmel Awadallah

Thumbnail for Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

ABCL - 1390

Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Interrupted Inpatient Continuity in DLBCL: Homelessness, Against-Medical-Advice Discharge, and Resource-Use Patterns in a Propensity Score-Matched NIS 2016-2020 Cohort

ABCL - 1408

Interrupted Inpatient Continuity in DLBCL: Homelessness, Against-Medical-Advice Discharge, and Resource-Use Patterns in a Propensity Score-Matched NIS 2016-2020 Cohort

Milan Regmi

Poster Presenter: Milan Regmi

Thumbnail for Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

ABCL - 142

Golcadomide-A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy

Muhamad Alhaj Moustafa

Poster Presenter: Muhamad Alhaj Moustafa

Thumbnail for Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

ABCL - 1431

Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

Saurav Das

Poster Presenter: Saurav Das

Thumbnail for Molecular Profiling of Chronic Lymphoproliferative Diseases in Brazilian Patients: A Real-World Next-Generation Sequencing Panel Experience

ABCL - 1434

Molecular Profiling of Chronic Lymphoproliferative Diseases in Brazilian Patients: A Real-World Next-Generation Sequencing Panel Experience

Andre Meireles

Poster Presenter: Andre Meireles

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.